Listen
We're still hearing about patient trials of the Ebola drug Remdesivir and the malaria drug Hydroxychloroquine for treatment of Covid-19 patients, but Nobel Prize-winning professor Peter Doherty, from the Department of Microbiology and Immunology at the University of Melbourne, says neither option is shaping as a potential remedy to the pandemic. There are more than 70 potential vaccines being developed at the moment, but he doesn't think a successful option will be in place anytime soon.
Peter Doherty Photo: Casamento Photography